LEADER 03797nam  2200901z- 450 
001 9910637783803321
005 20231214132954.0
010   $a3-0365-5765-2
035   $a(CKB)5470000001631699
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/94508
035   $a(EXLCZ)995470000001631699
100   $a20202212d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNew Trends on Vanadium Chemistry, Biochemistry, and Medicinal Chemistry
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (196 p.)
311   $a3-0365-5766-0 
330   $aThe recognition of the exceptional chemical and biological properties of vanadium compounds has led, in recent decades, to extensive research exploring their chemistry, biochemistry, and medicinal chemistry. Due to the prospective application of vanadium compounds as therapeutic agents against diseases such as diabetes, cancer and those provoked by parasites and bacteria, vanadium coordination chemistry and biochemistry has been an area of extensive research. Currently, the most promising potential uses of vanadium compounds are as nutritional supplements and as anticancer agents potentiated by immunotherapy. Nevertheless, researchers from all over the world are dedicating their efforts to vanadium research related to other potential therapeutic applications of vanadium compounds and to obtain insights into their beneficial effects on health and their modes of action. This Special Issue collected research contributions focused on recent advances in vanadium chemistry, biochemistry, and medicinal chemistry. I expect that this collection will have a great impact on the future direction of vanadium research.
606   $aResearch & information: general$2bicssc
606   $aChemistry$2bicssc
606   $aInorganic chemistry$2bicssc
610   $apolyoxometalates
610   $adecavanadate
610   $acytotoxicity
610   $ainsulin-like activity
610   $adiabetes therapy
610   $avanadium biochemistry
610   $avanadium speciation
610   $avanadium
610   $aproteins
610   $aDNA
610   $afluorescence
610   $abinding constants
610   $amechanism of action
610   $aoxidovanadium(V)
610   $avanadium Schiff base coordination complex
610   $alow acute toxicity
610   $aOxidovanadium(V)
610   $aSchiff base
610   $aX-ray crystallography
610   $aDNA interaction
610   $a2-aminopyrimidinium
610   $aexperimental and theoretical characterization
610   $aDFT
610   $adocking RNA/DNA
610   $avitamin E
610   $aEPR
610   $atocopherol
610   $a51V NMR
610   $aurethane
610   $aaerosol delivery
610   $alung cancer
610   $aapoptosis
610   $aantineoplastic
610   $aoxidovanadium(IV) phenantrholine chrysin
610   $avanadium cellular uptake
610   $aanticancer
610   $aalbumin interaction
610   $aglycosylated flavonoid
610   $aoxidovanadium(IV) complex
610   $aantitumoral
610   $aantioxidant
610   $acell signaling
610   $acancer
610   $aanticancer agents
615  7$aResearch & information: general
615  7$aChemistry
615  7$aInorganic chemistry
700   $aGambino$b Dinorah$4edt$01314919
702   $aGambino$b Dinorah$4oth
906   $aBOOK
912   $a9910637783803321
996   $aNew Trends on Vanadium Chemistry, Biochemistry, and Medicinal Chemistry$93032191
997   $aUNINA